Long-term follow-up of patients with systemic lupus erythematosus at Brest CHRU
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
This study follows patients with systemic lupus erythematosus to see how their condition changes over time and to gather information that can help improve treatment and understanding of the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Trial ID | NCT06551389 on ClinicalTrials.gov |
What this trial studies
This observational study aims to follow a cohort of patients with systemic lupus erythematosus (SLE) who are part of a multidisciplinary consultation at the University Hospital of Brest. The study will collect standardized data on the clinical, biological, and immunological patterns of SLE over time, involving specialists from various fields such as rheumatology, nephrology, and dermatology. The goal is to evaluate current practices, study the epidemiology of SLE in the region, and promote findings at both national and international levels.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who are receiving care at the multidisciplinary consultation for systemic lupus erythematosus.
Not a fit: Patients who oppose participation in the study will not benefit from this initiative.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of systemic lupus erythematosus, leading to improved patient outcomes.
How similar studies have performed: Other studies focusing on multidisciplinary approaches to autoimmune diseases have shown promise, indicating that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient over 18 years old of the multidisciplinary consultation Exclusion Criteria: * Opposition of patient
Where this trial is running
Brest
- CHRU de Brest — Brest, France (Recruiting)
Study contacts
- Study coordinator: Sandrine JOUSSE-JOULIN, Rheumatologist
- Email: sandrine.jousse-joulin@chu-brest.fr
- Phone: 33 (0)2-98-34-72-64
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.